Imperial Brands’ analyst price target has risen modestly from £32.60 to £33.15 as analysts cite slightly improved profit margin expectations along with a marginal reduction in discount rate assumptions.
What's in the News
- The U.S. Food and Drug Administration has permitted Juul Labs' original vaporizer and certain refill cartridges to remain on the U.S. market. This decision impacts major tobacco companies including Imperial Brands (WSJ).
- Imperial Brands has announced a share repurchase program of up to £1,450 million. The program is set to run until October 28, 2026.
- The Board of Directors approved a new buyback plan scheduled for October 7, 2025.
- Imperial Brands is seeking additional bolt-on acquisitions with a strategic focus on next-generation products to accelerate growth.
Valuation Changes
- Consensus Analyst Price Target has risen slightly from £32.60 to £33.15.
- Discount Rate has decreased modestly from 8.49% to 8.46%.
- Revenue Growth expectations have improved slightly, with the projected decline moving from -18.13% to -18.03%.
- Net Profit Margin has increased marginally from 25.13% to 25.16%.
- Future P/E ratio has edged up from 13.53x to 13.66x.
Have other thoughts on Imperial Brands?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.